Dr. Daniel John Cates, MD

Dr. Cates practices at UC Davis Medical Center in Sacramento, California, part of University of California Health.

Dr. Cates' NPI, 1821352907, was assigned on July 3, 2012. Dr. Cates graduated from University of Illinois College of Medicine - Chicago in 2012. Dr. Cates holds California license A127345.

Dr. Cates' primary practice is UC Davis Medical Center, at 2315 Stockton Boulevard, Sacramento, CA 95817 in Sacramento County. The practice phone is (916) 734-2011.

Dr. Cates' primary practice is UC Davis Medical Center in Sacramento, California, part of University of California Health. Dr. Cates is also affiliated with Hillcrest Medical Center. The medical group on file is UC Davis Medical Group. Dmand AI also links Dr. Cates to 3 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cates practices, 2 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Cates' primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Cates is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dmand AI has Dr. Cates' licenses on file in 2 states: California and Pennsylvania.

Dmand AI lists larynx and vocal cord disease among the conditions Dr. Cates treats.

CMS data shows 409 Medicare services from Dr. Cates across 10 procedure codes in 2024, for 223 Medicare patients. Medicare paid $33,729 for them.

CMS counts 223 Medicare patients who saw Dr. Cates in 2024. The largest group is 65 to 74, with 102 patients. 70% of them have high cholesterol, and 69% have high blood pressure. 25% are also on Medicaid. Their average risk score is 1.69, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Cates' median patient age at 53, with 54% women.

In 2024, Dr. Cates wrote 98 Medicare Part D claims for 42 patients. 99% of them were for generic drugs. CMS names the drug for 56 of them, across 2 drugs with 11 or more claims each, at $992 in total drug cost. In 2023, CMS named 90 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Cates for performance year 2024, reported as part of a group. Dr. Cates accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Cates as offering telehealth. CMS counts 23 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Cates, more than 52% of the clinicians it reports for that procedure.

Dmand AI links 39 papers to Dr. Cates, published from 2012 to 2025. 2023 was the busiest year, with 5. The most frequent topics are Deglutition Disorders, Deglutition and Dilatation. Dr. Cates has published most often in Laryngoscope. Dr. Cates' most frequent co-authors are Peter Charles Belafsky, MD, PhD, Maggie A. Kuhn, MD and Clark A. Rosen, MD.

Dmand AI links Dr. Cates to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Deglutition Disorders and Pharyngeal Diseases.

CMS Open Payments shows 13 general payments to Dr. Cates from 8 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 100% of the total. Intersect ENT, Inc. paid the most, $325.

Dr. Cates graduated from University of Illinois College of Medicine - Chicago in 2012.

Dr. Cates is in network with 13 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.